Advancing hepatic cell carcinoma treatment through mitochondrial DNA targeting

FHS
July 29, 2024
6:25 pm

Hepatic cell carcinoma (HCC), the fifth most prevalent malignancy worldwide and the fourth leading cause of cancer-related mortality, poses significant therapeutic challenges.

Researchers make new breakthrough in better understanding the immune system to fight diseases

The Xue Lab at the Hackensack Meridian Center for Discovery and Innovation (CDI) has made another breakthrough in better understanding, and potentially modulating, the immune

January 19, 2024

Revolutionary stem cell culture method produces full model of human central nervous system

The first stem cell culture method that produces a full model of the early stages of the human central nervous system has been developed by

February 26, 2024

Sanofi partners with Synthekine in immunology race

Synthekine is teaming up with Sanofi in a $40 million-plus collaboration to develop IL-10 receptor agonists for autoimmune and inflammatory diseases. The cytokine-focused biotech will

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.